Nektar Therapeutics Tumbles Despite Long-Term Benefit From Alopecia Drug

Nektar stock took a hit Thursday despite test results that suggested its drug has long-term benefits for alopecia patients.

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investors.com)